Financials
- Market Capitalization 362.79 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.61
市销率
54.94
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3146 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.67 USD | -1.19% | +0.30% | +1.06% | +26.09% | 359.68 M USD | ||
| 3159 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.51 USD | -3.01% | -1.69% | +12.74% | -40.02% | 355.57 M USD | ||
| 3200 | PALI Palisade Bio, Inc. - Common Stock | 2.01 USD | +1.01% | -5.63% | +4.69% | +18.24% | 350.28 M USD | ||
| 3212 | STRO Sutro Biopharma, Inc. - Common Stock | 20.43 USD | -0.20% | -4.84% | -19.09% | +17.48% | 338.75 M USD |